Login / Signup

Targeted Screening for Barrett's Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial.

W Keith TanRoberta MaroniJudith OffmanShahriar A Zamaninull nullPeter D SasieniRebecca C Fitzgerald
Published in: Gastroenterology (2024)
Keyphrases
  • phase iii
  • phase ii
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • study protocol
  • cancer therapy
  • randomized controlled trial
  • drug delivery